Internal Medicine, Critical Care Medicine · Gainesville, FL
NPI
1891002697
Since 2010
Specialty
Internal Medicine, Critical Care Medicine
Code 207RC0200X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
1600 SW Archer Rd
Gainesville, FL, 32610
Phone (352) 273-8740
Groups this clinician bills Medicare through
Medicare paid, 2024
$87K
2,444 services
Medicare patients, 2024
859
Average age 71
Drug cost, 2024
$3.4M
2,810 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Natalia I Moguillansky was code 94729 (pulmonary function testing), 375 times for 364 patients. In total Natalia I Moguillansky billed 2,444 services in 36 codes, and Medicare paid $87K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-12-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 94729 Pulmonary Function Testing | Facility | 375 | 364 | $6.75 | $2,531 |
| 94726 Pulmonary Function Testing | Facility | 315 | 308 | $9.03 | $2,844 |
| 94010 Pulmonary Function Testing | Facility | 313 | 193 | $6.22 | $1,947 |
| 94060 Pulmonary Function Testing | Facility | 307 | 302 | $7.75 | $2,379 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 244 | 189 | $12.71 | $3,102 |
| 99214 Office E&M - Established | Office | 183 | 158 | $92.31 | $17K |
| 99215 Office E&M - Established | Office | 161 | 121 | $135.71 | $22K |
| 99421 Office/Outpatient Services | Office | 81 | 50 | $11.68 | $946 |
| 99204 Office E&M - New | Office | 49 | 49 | $123.34 | $6,044 |
| 99231 Hospital E&M - Subsequent | Facility | 48 | 29 | $38.66 | $1,856 |
| 94618 Pulmonary Function Testing | Facility | 45 | 44 | $16.57 | $746 |
| 31624 Bronchoscopy | Facility | 40 | 38 | $98.99 | $3,959 |
| 99222 Hospital E&M - Initial | Facility | 32 | 29 | $102.38 | $3,276 |
| 36415 Venipuncture Blood Collection | Office | 32 | 25 | $8.65 | $277 |
| 99213 Office E&M - Established | Office | 32 | 30 | $65.08 | $2,083 |
By year: 2022 $71K for 1,597 services; 2023 $90K for 2,384 services; 2024 $87K for 2,444 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 32 | 25 | $8.65 | $277 |
Medicare prescription drug claims, 2024
In 2024, the drug Natalia I Moguillansky prescribed most often to Medicare patients was Montelukast Sodium, with 348 prescriptions and refills. In total Natalia I Moguillansky wrote 2,810 Medicare prescriptions that cost $3.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Montelukast Sodium Generic | 348 | 885 | 124 | $4,171 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 338 | 693 | 99 | $421K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 281 | 535 | 106 | $15K |
| Fluticasone Propionate Generic | 185 | 465 | 75 | $4,675 |
| Advair Hfa Fluticasone Propion/Salmeterol | 120 | 256 | 45 | $105K |
| Spiriva Respimat Tiotropium Bromide | 120 | 284 | 50 | $146K |
| Azithromycin Generic | 118 | 258 | 56 | $6,251 |
| Ventolin Hfa Albuterol Sulfate | 110 | 193 | 43 | $14K |
| Prednisone Generic | 102 | 119 | 52 | $467 |
| Arikayce Amikacin Liposomal/Neb.Accessr | 87 | 87 | 15 | $1.3M |
| Symbicort Budesonide/Formoterol Fumarate | 86 | 173 | 36 | $40K |
| Nucala Mepolizumab | 81 | 81 | 13 | $300K |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 64 | 144 | 22 | $19K |
| Spiriva Handihaler Tiotropium Bromide | 55 | 121 | 13 | $61K |
| Ethambutol Hcl Generic | 51 | 142 | 23 | $7,069 |
Brand drugs: 1,597 claims; generic drugs: 1,213 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Natalia I Moguillansky were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.